The Impact of Mood Disorders on the Delivery and Neonatal Outcomes of Methadone-Maintained Pregnant Patients

REFERENCES

• Fitzsimons H E, Tuten M, Vaidya V, Jones H E. Mood disorders affect drug treatment success of drug-dependent pregnant women. J Substance Abuse Treat 2007; 32: 19–25
   PubMed Web of Science ®Google Scholar
• Raudzus J, Mizri S. Managing unipolar depression in pregnancy. Curr Opin Psychiatry 2009; 22(1)13–18
   Google Scholar
• Bennett H A, Einarson A, Taddio A, Koren G, Einarson T R. Prevalence of depression during pregnancy: Systematic review. Obstet Gynecol 2004; 103: 698–709
   PubMed Web of Science ®Google Scholar
• Field T, Diego M, Hernandez-Reif M, Figueiredo B, Schanberg S, Kuhn C, Deeds O, Contogeorgos J, Ascencio A. Chronic prenatal depression and neonatal outcome. Int J Neurosci 2008; 118: 95–103
   PubMed Web of Science ®Google Scholar
• Misri S, Kendrick K. Treatment of perinatal mood and anxiety disorders: A review. Can J Psychiatry 2007; 52: 489–498
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse. National Pregnancy & Health Survey: Drug Use Among Women Delivering Live Births: 1992. U.S. Department of Health and Human Services, U.S. Government Printing Office, Washington, DC 1996
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Office of Applied Studies, Treatment Episode Data Set (TEDS): 1996–2006. National Admission to Substance Abuse Treatment Services, Rockville, MD 2008, DASIS Series: S-43, DHHS Pub. (SMA-08-4347)
   Google Scholar
• Haller D L, Knisely J S, Dawson K S, Schnoll S H. Perinatal substance abusers: Psychological and social characteristics. J Nerv Ment Dis 1993; 181: 509–513
   PubMed Web of Science ®Google Scholar
• Haller D L, Miles D, Dawson K. Psychopathology influences treatment retention among drug-dependent women. J Substance Abuse Treat 2002; 23: 431–436
   PubMed Web of Science ®Google Scholar
• Finnegan L P, Oehlberg S M, Regan D, Rudrauff M. Evaluation of parenting, depression and violence profiles in methadone maintained women. Child Abuse Neglect 1981; 5: 267–273
   Google Scholar
• Cohen M M, Ansara D, Schei B, Stuckless N, Stewart D E. Posttraumatic stress disorder after pregnancy, labor, and delivery. J Womens Health (Larchmt) 2004; 13: 315–324
   PubMed Web of Science ®Google Scholar
• Diego M A, Field T, Hernandez-Reif M, Schanberg S, Kuhn C, Gonzalez-Quintero V H. Prenatal depression restricts fetal growth. Early Hum Dev 2008; 85: 65–70
   Google Scholar
• Diego M A, Field T, Hernandez-Reif M, Cullen C, Schanberg S, Kuhn C. Prepartum, postpartum, and chronic depression effects on newborns. Psychiatry 2004; 67: 63–80
   PubMed Web of Science ®Google Scholar
• Field T, Diego M, Hernandez-Reif M, Figueiredo B, Schanberg S, Kuhn C. Sleep disturbances in depressed pregnant women and their newborns. Infant Behav Dev 2007; 30: 127–133
   PubMed Web of Science ®Google Scholar
• Zuckerman B, Bauchner H, Parker S, Cabral H. Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Behav Pediatr 1990; 11: 190–194
   PubMed Web of Science ®Google Scholar
• Hulse G K, Milne E, English D R, Holman C D. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997; 92: 1571–1579
   PubMed Web of Science ®Google Scholar
• Messinger D S, Bauer C R, Das A, Seifer R, Lester B M, Lagasse L L, Wright L L, Shankaran S, Bada H S, Smeriglio V L, Langer J C, Beeghly M, Poole W K. The maternal lifestyle study: Cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics 2004; 113: 1677–1685
   PubMed Web of Science ®Google Scholar
• Lester B M, Andreozzi L, Appiah L. Substance use during pregnancy: Time for policy to catch up with research. Harm Reduction J 2004; 1: 5–49
   PubMedGoogle Scholar
• Finnegan L P. Treatment issues for opioid dependent women during the perinatal period. J Psychoactive Drugs 1991; 23: 191–202
   PubMed Web of Science ®Google Scholar
• Jones H E, O'Grady K E, Malfi D, Tuten M. Methadone maintenance vs. methadone taper during pregnancy: Maternal and neonatal outcomes. Am J Addict 2008; 17: 372–386
   PubMed Web of Science ®Google Scholar
• Svikis D S, Lee J H, Haug N A, Stitzer M L. Attendance incentives for outpatient treatment: Effects in methadone- and non-methadone-maintained pregnant drug dependent women. Drug and Alcohol Depend 1997; 48: 33–41
   PubMed Web of Science ®Google Scholar
• Kandall S R, Albin S, Gartner L M, Lee K S, Eidelman A, Lowinson J. The narcotic-dependent mother: Fetal and neonatal consequences. Early Human Dev 1977; 1: 159–69
   PubMed Web of Science ®Google Scholar
• First M, Spitzer R, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis Disorders. Biometrics Research, State Psychiatric Institute, New York, NY 1995
   Google Scholar
• Nair P, Schuler M E, Black M M, Kettinger L, Harrington D. Cumulative environmental risk in sustance abusing women: Early intervention, parenting stress, child abuse potential and child development. Child Abuse Negl 2003; 27: 997–1017
   PubMed Web of Science ®Google Scholar
• Strain E C, Stitzer M L, Bigelow G E. Early treatment time course of depressive symptoms in opiate addicts. J Nerv Ment Dis 1991; 179: 215–221
   PubMed Web of Science ®Google Scholar